Trials / Completed
CompletedNCT02612064
The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 488 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This single centre, dual site, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stannous Fluoride dentifice | Experimental dentifrice containing 0.454% w/w stannous fluoride (1100ppm) |
| OTHER | Sodium Monofluorophosphate dentifrice | Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride) |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-06-03
- Completion
- 2016-06-03
- First posted
- 2015-11-23
- Last updated
- 2017-05-17
- Results posted
- 2017-03-23
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02612064. Inclusion in this directory is not an endorsement.